Loading...

Mirati Therapeutics, Inc.

MRTXNASDAQ
Healthcare
Biotechnology
$58.70
$-0.10(-0.17%)

Mirati Therapeutics, Inc. (MRTX) Stock Overview

Explore Mirati Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.5/100

Key Financials

Market Cap4.1B
P/E Ratio-4.46
EPS (TTM)$-12.18
ROE-0.62%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

MRTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mirati Therapeutics, Inc. (MRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.46 and a market capitalization of 4.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;